Skip to main content
SpringerLink
Log in

Irreversible Electroporation Techniques in the Treatment of Locally Advanced Liver and Pancreatic Cancer

  • Living reference work entry
  • First Online:
Handbook of Electroporation

  • 160 Accesses

Abstract

Initially diagnosed stage 3 (locally advanced) pancreatic adenocarcinoma (LAPC) remains an aggressive tumor with an overall poor prognosis (current median survival chemotherapy and radiation therapy of 9–12 months). Improvement in survival can be achieved in the small percentage that can undergo an R0 resection or where all macroscopic tumors can be cleared by local ablation. Long-duration (>4–6 months) chemoradiotherapy is not tolerated by all patients and still fails to prolong survival alone. Neoadjuvant treatment also has limited results on pain control or tumor downstaging since most current modalities do not shrink or downsize the tumor. In recent years, there has been a growing interest in the use of local ablative therapy for the treatment of nonresectable tumors in various organs. Ablation techniques are based on direct application of chemical, thermal, or electrical energy to a tumor, which leads to cellular necrosis without removal of the tumor. With ablation, local control and relief from symptoms can be obtained in the majority of the patients when appropriate patient selection and technique are utilized. LAPC has been treated by various ablation techniques in the last few years with promising results. This represents the current status of local ablative therapies in the treatment of LAPC and investigates the efficacy and future trends.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  • Agle SCPPVTS B, Scherer M, Ramsey C, Dumpuri P, Neese B, Martin RCG (2015) Intra-operative navigation of a 3dimensional needle localization system for precision of irreversible electroporation needles in locally advanced pancreatic cancer. Surgery; Under review

    Google Scholar 

  • Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, Davalos RV et al (2007) Tumor ablation with irreversible electroporation. PLoS One 2:e1135

    Article  Google Scholar 

  • Bower M, Sherwood L, Li Y, Martin R (2011) Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol 104:22–28

    Article  Google Scholar 

  • Callery MP, Chang KJ, Fishman EK, Talamonti MS, William Traverso L, Linehan DC (2009) Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol 16:1727–1733

    Article  Google Scholar 

  • Cannon R, Ellis S, Hayes D, Narayanan G, Martin RC 2nd (2013) Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 107:544–549

    Article  Google Scholar 

  • Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE (2010) Irreversible electroporation of the pancreas in swine: a pilot study. HPB (Oxford) 12:348–351

    Article  Google Scholar 

  • Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE (2011) Irreversible electroporation of the liver and liver hilum in swine. HPB (Oxford) 13:168–173

    Article  Google Scholar 

  • Conroy T, Desseigne F, Ychou M, Bouche O, Guimbaud R, Becouarn Y et al (2011) FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 364:1817–1825

    Article  Google Scholar 

  • Davalos RV, Mir IL, Rubinsky B (2005a) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223–231

    Article  Google Scholar 

  • Dunki-Jacobs EM, Philips P, Martin Ii RC (2014a) Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model. Br J Surg 101:1113–1121

    Article  Google Scholar 

  • Dunki-Jacobs EM, Philips P, Martin RC 2nd (2014b) Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas. J Am Coll Surg 218:179–187

    Article  Google Scholar 

  • Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B (2006) In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 53:1409–1415

    Article  Google Scholar 

  • Escobar-Chavez JJ, Bonilla-Martinez D, Villegas-Gonzalez MA, Revilla-Vazquez AL (2009) Electroporation as an efficient physical enhancer for skin drug delivery. J Clin Pharmacol 49:1262–1283

    Article  Google Scholar 

  • Ghaneh P, Kawesha A, Howes N, Jones L, Neoptolemos JP (1999) Adjuvant therapy for pancreatic cancer. World J Surg 23:937–945

    Article  Google Scholar 

  • Goel R, Anderson K, Slaton J, Schmidlin F, Vercellotti G, Belcher J et al (2009) Adjuvant approaches to enhance cryosurgery. J Biomech Eng 131:074003

    Article  Google Scholar 

  • Granot Y, Rubinsky B (2008) Mass transfer model for drug delivery in tissue cells with reversible electroporation. Int J Heat Mass Transf 51:5610–5616

    Article  MATH  Google Scholar 

  • Groeschl RT, Wong RK, Quebbeman EJ, Tsai S, Turaga KK, Pappas SG et al (2013) Recurrence after microwave ablation of liver malignancies: a single institution experience. HPB (Oxford) 15:365–371

    Article  Google Scholar 

  • Guo Y, Zhang Y, Klein R, Nijm GM, Sahakian AV, Omary RA et al (2010) Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res 70:1555–1563

    Article  Google Scholar 

  • Guo Y, Zhang Y, Nijm GM, Sahakian AV, Yang GY, Omary RA et al (2011) Irreversible electroporation in the liver: contrast-enhanced inversion-recovery MR imaging approaches to differentiate reversibly electroporated penumbra from irreversibly electroporated ablation zones. Radiology 258:461–468

    Article  Google Scholar 

  • Habash RW, Bansal R, Krewski D, Alhafid HT (2007) Thermal therapy, part III: ablation techniques. Crit Rev Biomed Eng 35:37–121

    Article  Google Scholar 

  • Hu J, Zhao G, Wang HX, Tang L, Xu YC, Ma Y et al (2011) A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma. J Hematol Oncol 4:11

    Article  Google Scholar 

  • Huguet F, Andre T, Hammel P, Artru P, Balosso J, Selle F et al (2007) Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. J Clin Oncol Off J Am Soc Clin Oncol 25:326–331

    Article  Google Scholar 

  • Jemal A, Thomas A, Murray T, Thun M (2002) Cancer statistics, 2002. CA Cancer J Clin 52:23–47

    Article  Google Scholar 

  • Jurgensen C, Schuppan D, Neser F, Ernstberger J, Junghans U, Stolzel U (2006) EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc 63:1059–1062

    Article  Google Scholar 

  • Kingham TP, Scherer MA, Neese BW, Clements LW, Stefansic JD, Jarnagin WR (2012) Image-guided liver surgery: intraoperative projection of computed tomography images utilizing tracked ultrasound. HPB (Oxford) 14:594–603

    Article  Google Scholar 

  • Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST (2010) Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255:426–433

    Article  Google Scholar 

  • Loehrer PJ Sr, Feng Y, Cardenes H, Wagner L, Brell JM, Cella D et al (2011) Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an eastern cooperative oncology group trial. J Clin Oncol Off J Am Soc Clin Oncol 29:4105–4112

    Article  Google Scholar 

  • Maor E, Ivorra A, Leor J, Rubinsky B (2007a) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6:307–312

    Article  Google Scholar 

  • Martin RC (2013a) Irreversible electroporation of locally advanced pancreatic head adenocarcinoma. J Gastrointest Surg 17:1850–1856

    Article  Google Scholar 

  • Martin RCG (2013b) Irreversible electroporation: a novel option for treatment of hepatic metastases. Curr Colorectal Cancer Rep 9:191–197

    Article  Google Scholar 

  • Martin RCG (2015a) Irreversible electroporation in locally advanced pancreatic adenocarcinoma of body/neck. J Gastrointest Oncol 6:329–335

    Google Scholar 

  • Martin RCG (2015b) Use of irreversible electroporation in unresectable pancreatic cancer. HepatoBiliary Surg Nutr 4:211–215

    Google Scholar 

  • Martin RC, Scoggins CR, McMasters KM (2010) Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience. Ann Surg Oncol 17:171–178

    Article  Google Scholar 

  • Martin RC 2nd, McFarland K, Ellis S, Velanovich V (2012) Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. J Am Coll Surg 215:361–369

    Article  Google Scholar 

  • Martin RC 2nd, McFarland K, Ellis S, Velanovich V (2013) Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol 20(Suppl 3):S443–S449

    Article  Google Scholar 

  • Martin RC, Philips P, Ellis S, Hayes D, Bagla S (2014) Irreversible electroporation of unresectable soft tissue tumors with vascular invasion: effective palliation. BMC Cancer 14:540

    Article  Google Scholar 

  • Martin RC 2nd, Kwon D, Chalikonda S, Sellers M, Kotz E, Scoggins C et al (2015) Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy. Ann Surg 262:486–494

    Article  Google Scholar 

  • Narayanan G, Hosein PJ, Arora G, Barbery KJ, Froud T, Livingstone AS et al (2012) Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol 23:1613–1621

    Article  Google Scholar 

  • North DA, Groeschl RT, Sindram D, Martinie JB, Iannitti DA, Bloomston M et al (2014) Microwave ablation for hepatic malignancies: a call for standard reporting and outcomes. Am J Surg 208:284–294

    Article  Google Scholar 

  • Philips P, Hays D, Martin RC (2013) Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated. PLoS One 8:e76260

    Article  Google Scholar 

  • Philips P, Li Y, Li S, St Hill CR, Martin RCG (2015) Efficacy of irreversible electroporation in human pancreatic adenocarcinoma: advanced murine model. Mol Ther Method Clin Dev 2:15001

    Article  Google Scholar 

  • Prud’homme GJ, Glinka Y, Khan AS, Draghia-Akli R (2006) Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr Gene Ther 6:243–273

    Article  Google Scholar 

  • Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913–2921

    Article  Google Scholar 

  • Robinson D, Halperin N, Nevo Z (2001) Two freezing cycles ensure interface sterilization by cryosurgery during bone tumor resection. Cryobiology 43:4–10

    Article  Google Scholar 

  • Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality – clinical implications. Technol Cancer Res Treat 6:37–48

    Article  Google Scholar 

  • Spinelli GP, Zullo A, Romiti A, Di Seri M, Tomao F, Miele E et al (2006) Long-term survival in metastatic pancreatic cancer. A case report and review of the literature. JOP 7:486–491

    Google Scholar 

  • Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205–216

    Article  Google Scholar 

  • Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H et al (2006) Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 13:1035–1046

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, University of Louisville, 315 E. Broadway – M10 - Rm#312, Louisville, KY, 40202, USA

    Robert CG Martin

Authors
  1. Robert CG Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert CG Martin .

Editor information

Editors and Affiliations

  1. Faculty of Electrical Enginer, University of Ljubljana, Ljubljana, Slovenia

    Damijan Miklavcic

Section Editor information

  1. Department of Experimental Oncology, Institute of Oncology Ljubljana, Zaloska cesta 2, SI-1000, Ljubljana, Slovenia

    Gregor Sersa

  2. Frank Reidy Research Center for Bioelectrics, Old Dominion University, 4211 Monarch Way, Suite 300, 23508, Norfolk, VA, USA

    Richard Heller

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this entry

Cite this entry

Martin, R.C. (2017). Irreversible Electroporation Techniques in the Treatment of Locally Advanced Liver and Pancreatic Cancer. In: Miklavcic, D. (eds) Handbook of Electroporation. Springer, Cham. https://doi.org/10.1007/978-3-319-26779-1_111-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26779-1_111-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26779-1

  • Online ISBN: 978-3-319-26779-1

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics

Societies and partnerships

Search

Navigation